Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Jan Lammers

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Journal of Neuroimmunology|March 18, 2020
HLA associations in narcolepsy type 1 persist after the 2009 H1N1 pandemicMink Schinkelshoek, Rolf Fronczek, Willem Verduijn, et al.
Journal of Sleep Research|March 6, 2018
Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1Mink S Schinkelshoek, Isabelle M Smolders, Claire E Donjacour, et al.
Brain Pathology (Zurich, Switzerland)|May 24, 2008
Hypocretin and melanin-concentrating hormone in patients with Huntington diseaseAhmad Aziz, Rolf Fronczek, Marion Maat-Schieman, et al.
Sleep|November 15, 2024
Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetryClaire E H M Donjacour, Jari K Gool, Paul F Schoffelen, et al.
Journal of Sleep Research|August 19, 2011
Severe fatigue in narcolepsy with cataplexyHal A Droogleever Fortuyn, Rolf Fronczek, Mirjan Smitshoek, et al.
Sleep|May 13, 2022
Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1Adrienne Elisabeth van der Hoeven, Rolf Fronczek, Mink Sebastian Schinkelshoek, et al.
Journal of Neurology|January 17, 2003
Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinomaPaul W Wirtz, Peter A E Sillevis Smitt, Jorrit I Hoff, et al.
Brain : a Journal of Neurology|May 2, 2007
Hypocretin (orexin) loss in Parkinson's diseaseRolf Fronczek, Sebastiaan Overeem, Sandy Y Y Lee, et al.
Sleep|May 5, 2022
Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantificationAdrienne Elisabeth van der Hoeven, Kevin van Waaij, Denise Bijlenga, et al.
The Lancet. Neurology|October 11, 2013
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trialYves Dauvilliers, Claudio Bassetti, Gert Jan Lammers, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Journal of Neuroimmunology|March 18, 2020
HLA associations in narcolepsy type 1 persist after the 2009 H1N1 pandemicMink Schinkelshoek, Rolf Fronczek, Willem Verduijn, et al.
Journal of Sleep Research|March 6, 2018
Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1Mink S Schinkelshoek, Isabelle M Smolders, Claire E Donjacour, et al.
Brain Pathology (Zurich, Switzerland)|May 24, 2008
Hypocretin and melanin-concentrating hormone in patients with Huntington diseaseAhmad Aziz, Rolf Fronczek, Marion Maat-Schieman, et al.
Sleep|November 15, 2024
Measuring energy expenditure in narcolepsy using doubly labeled water and respiration chamber calorimetryClaire E H M Donjacour, Jari K Gool, Paul F Schoffelen, et al.
Journal of Sleep Research|August 19, 2011
Severe fatigue in narcolepsy with cataplexyHal A Droogleever Fortuyn, Rolf Fronczek, Mirjan Smitshoek, et al.
Sleep|May 13, 2022
Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1Adrienne Elisabeth van der Hoeven, Rolf Fronczek, Mink Sebastian Schinkelshoek, et al.
Journal of Neurology|January 17, 2003
Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinomaPaul W Wirtz, Peter A E Sillevis Smitt, Jorrit I Hoff, et al.
Brain : a Journal of Neurology|May 2, 2007
Hypocretin (orexin) loss in Parkinson's diseaseRolf Fronczek, Sebastiaan Overeem, Sandy Y Y Lee, et al.
Sleep|May 5, 2022
Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantificationAdrienne Elisabeth van der Hoeven, Kevin van Waaij, Denise Bijlenga, et al.
The Lancet. Neurology|October 11, 2013
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trialYves Dauvilliers, Claudio Bassetti, Gert Jan Lammers, et al.
Pageof 16